• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Pergolide
Date Designated: 11/20/1997
Orphan Designation: Treatment of Tourette's syndrome.
Orphan Designation Status: Designated/Withdrawn
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sallee, Floyd R. M.D., Ph.D.
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave.
Cincinnati, Ohio 45229
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.